NASDAQ
NGM Biopharmaceuticals, Inc. (NGM) has a eps (basic) of $-1.73 as of Sunday, December 31, 2023. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.